AtriCure Inc. (ATRC) PT Lowered to $55 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Mike Matson lowered the price target on AtriCure Inc. (NASDAQ: ATRC) to $55.00 (from $67.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
